Etiology and pathophysiology of chronic transplant dysfunction

Transplant International

Volumn 13, Issue 6, 2000, Pages 385-401

  Kouwenhoven, Ewout A ^a   IJzermans, J N M ^a   De Bruin, Ron W F ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Chronic transplant dysfunction; Etiology; Pathophysiology; Review

Indexed keywords

CYTOKINE; GROWTH FACTOR;

ENDOTHELIUM; EXTRACELLULAR MATRIX; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; KIDNEY TRANSPLANTATION; MACROPHAGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOOTH MUSCLE FIBER;

ACUTE DISEASE; ANIMALS; CADAVER; CHRONIC DISEASE; COHORT STUDIES; CYTOKINES; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; GRAFT REJECTION; GRAFT SURVIVAL; GROWTH SUBSTANCES; HUMANS; HYPERPLASIA; IMMUNOSUPPRESSIVE AGENTS; ISCHEMIA; ISOANTIBODIES; MACROPHAGE ACTIVATION; MICE; MULTICENTER STUDIES; MUSCLE, SMOOTH, VASCULAR; POSTOPERATIVE COMPLICATIONS; RATS; RISK FACTORS; T-LYMPHOCYTE SUBSETS; TISSUE DONORS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; TUNICA INTIMA;

EID: 0033637051     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470050721     Document Type: Review

References (236)

1. Ten years of liver transplantation: An evolving understanding of late graft loss
2. Monitoring and treatment of intestinal allograft rejection in humans
3. Hypercholesterolemia does not exacerbate arterial intimal thickening in chronically rejecting rat cardiac allografts
4. Chronic rejection in experimental cardiac transplantation: Studies in the Lewis-F344 model
5. Renal function changes over time in adult recipients of small pediatric kidneys. Evidence against hyperperfusion injury
6. Risk factors for chronic rejection in renal allograft recipients
7. Studies on the pathogenesis of atherosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia
8. Relative importance of ischemic injury and immunological injury on the development of transplant arteriosclerosis in rabbit aortic allografts
9. Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney
10. Prevention of functional, structural, and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor
11. Intragraft cytokine and growth factor mRNA expression in relation to graft vascular disease after heart transplantation
12. Causes of late graft loss after liver transplantation
13. Immune responses to allografts. Marked decrease in medullary thymocytes and splenic T lymphocytes after cyclosporin A treatment
14. Complement in organ transplantation
15. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management
16. Lipoprotein (a) and accelerated coronary artery disease in cardiac allograft recipients
17. Early versus late acute renal allograft rejection: Impact on chronic rejection
18. Effect of human leucocyte antigen matching on the incidence of acute rejection in renal transplantation
19. Xanthine oxidase-derived superoxide causes reoxygenation injury of ischemic cerebral endothelial cells
20. Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function
21. Complications in long term survivors of cardiac transplantation
22. Patient non-compliance as a cause of late kidney graft failure
23. In renal transplantation, one size may not fit all
24. Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular endothelial cell adhesion molecule-1 in vivo: Correlation with CD3 + T cell infiltration
25. Induced expression of endothelial-leucocyte adhesion molecules in human cardiac allografts
26. Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease
27. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury
28. Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival
29. Identification of differently expressed genes in rat aortic allograft vasculopathy
30. Inhibition of myointimal hyperplasia and macrophage infiltration by oestradiol in aorta allografts
31. Antigen-independent determinants of cadaveric kidney transplant failure
32. Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection
33. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts
34. Mixed allogeneic chimerism in the rat -donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts
35. Cellular and molecular mechanisms of allograft rejection
36. Importance of minimizing HLA-DR mismatch and cold preservation time m cadaveric renal transplantation
37. Impact of acute rejection and early allograft function on renal allograft survival
38. Heart transplant coronary artery disease detected by coronary angiography: A multiinstitutional study of preoperative donor and recipient risk factors
39. Cardiac transplantation in the rat. II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host response
40. Renal transplant: Correlations of histological patterns with function in the kidney
41. Human CD4 helper T cell activation: Functional involvement of two distinct collagen receptors, IF7 and VLA integrin family
42. Renal allograft survival in African-Americans: Influence of the Duffy blood group
43. Development of cytotoxic antibodies following renal allograft transplantation is associated with reduced graft survival due to chronic vascular rejection
44. Chronic rejection of liver transplants revisited
45. Progressive albuminuria and glomerulosclerosis in a rat model of chornic renal allograft rejection
46. Hyperlipoproteinemia in renal transplant recipients: Is there a linkage with chronic rejection?
47. High incidence of anti-tissue antibodies in patients experiencing chronic liver allograft rejection
48. Chronic renal allograft rejection. Selective involvement of the glomerular endothelium in humoral immune reactivity and intravascular coagulation
49. Causes of graft loss beyond two years in the cyclosporine era
50. Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors
51. Living related and cadaveric kidney transplantation-What are the major differences?
52. Nonimmunological factors involved in long-term renal allograft deterioration
53. Accelerated atherosclerosis in heart transplants in the rat simulating chronic vascular rejection: Effects of prostacyclin and angiopeptin
54. Rapidly proliferating arteriopathy in cyclosporin-induced permanently surviving rat cardiac allografts simulating chronic vascular rejection
55. Acute rejection episodes - Best predictor of long-term primary cadaveric renal transplant survival
56. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: Association with chronic rejection
57. Gender effects on myointimal hyperplasia
58. Chronic rejection after liver transplantation: A study of clinical, histopathological and immunological features
59. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulphate moiety of subendothelial extracellular matrix
60. Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys - Correlation with intragraft events
61. Clinical and laboratory correlates of accelerated coronary disease in the cardiac transplant patient
62. Accelerated arteriosclerosis in aortic grafts: A role for activated complement and IgM antibody in early lesion development
63. Suppression of acute rejection prevents graft arteriosclerosis after allogeneic aorta transplantation in the rat
64. Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix
65. A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS update
66. Survival trends in long-term first cadaver-donor kidney transplants
67. Human renal isografts: A clinical and pathologic analysis
68. Current results of intestinal transplantation
69. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis
70. Ischemia-reperfusion injury as a risk factor for late kidney graft failure
71. Early function as the principal correlate of graft survival
72. The mediators of inflammation (interleukin-1, Interferon-γ, and Tumor necrosis factor) and their relevance to rejection
73. The significance of anti class I response. Clinical and pathological features of renal transplants with anti class I antibody
74. The regulation of expression of major histocompatibility complex products
75. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts
76. LEW-to-F344 carotid artery allografts: Analysis of a rat model of posttransplant vascular injury involving cell-mediated and humoral responses
77. Risk factors for renal allograft survival from older cadaver donors
78. Induction of high affinity fibroblast growth factor receptor expression and proliferation in human endothelial cells by anti-HLA antibodies: A possible mechanism for transplant atherosclerosis
79. Towards understanding the pathophysiology of chronic rejection
80. Molecular biology of chronic rejection and predictive value of biopsies
81. The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats
82. Early patterns of cellular infiltration and cytokine and extracellular matrix protein expression reflect reperfusion injury after cardiac transplantation in rats
83. Chronic renal allograft rejection in the rat Transplantation-induced antibodies against basement membrane antigens
84. Early treatment of acute rejection prevents chronic rejection in a rat model of allogenic left lung transplantation
85. Induction of organ dysfunction and activation of inflammatory markers in donor liver and kidney during hypotensive brain death
86. Influence of acute rejection episodes, HLA matching, and donor/recipient phenotype on the development of 'early' transplant-associated coronary artery disease
87. Influence of HLA matching on thoracic transplant outcomes. An analysis from the UNOS/ISHLT Thoracic Registry
88. Cardiac allograft vasculopathy: IgM antibody responses to donor-specific vascular endothelium
89. Accelerated arteriosclerosis in hear transplant recipients is associated with a T-lymphocyte-mediated endothelialitis
90. The association between acute rejection and chronic rejection in kidney transplantation
91. Immunohistochemical manifestations of unilateral kidney ischemia
92. Hypoxia/reoxygenation increases the permeability of endothelial cell monolayers: Role of oxygen radicals
93. Glomerulosclerosis induced by in vivo transfection of transforming growth factor β or platelet derived growth factor gene into the rat kidney
94. Histopathological findings in well-functioning, long-term renal allografts
95. Evidence that graft coronary arteriosclerosis begins in the early phase after transplantation and progresses without chronic immunoreaction. Histopathological analysis using a retransplantation model
96. Primary liver transplantation in infants, children, adults, and seniors:1000 consecutive patients from single centre with 5 to 8 years actual follow-up
97. Humoral antibodies in renal allotransplantation in man
98. The effect of race and ethnicity on kidney allograft outcome
99. Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft
100. Immune sources of transforming growth factor-betal reduce transplant arteriosclerosis: Insight derived from a knockout mouse model
101. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts
102. Late graft dysfunction after prolonged cold ischemia of the donor kidney. Inhibition by cyclosporine
103. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation
104. Systemic hypertension accelerates chronic rejection of renal allografts in the rat
105. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants
106. Persistent cytomegalovirus in liver allografts with chronic rejection
107. Effect of cytomegalovirus on an experimental model of chronic renal allograft rejection under triple-drug treatment in the rat
108. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aorticallografts
109. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection
110. Leucocyte interactions with vascular endothelium-New insights into selectin-mediated attachment and rolling
111. Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis
112. The pathogenesis of coronary arteriosclerosis (chronic rejection) in transplanted hearts
113. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary cadaveric renal transplants treated by 3 cyclosporine regimens
114. Inhibition of transplant coronary arteriosclerosis in rabbits by chronic oestradiol treatment is associated with abolition of MHC class II antigen expression
115. Renal mass as a determinant of late allograft outcome: Insights from experimental studies in rats
116. Purified intercellular adhesion moleclule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1)
117. Monocyte Fc gamma receptor crosslinking induces IL-8 production
118. Fc gamma receptor crosslinking induces peripheral blood mononuclear cell MCP-1 expression
119. Post-transplant antidonor lymphocytotoxic antibody production in relation to graft outcome
120. Chronic renal allograft rejection: Immunologic and non-immunologic risk factors
121. Half-life and risk factors for kidney transplant outcome- importance of death with function
122. Chronic rejection in renal transplants - Risk factors and correlates
123. The impact of an acute rejection epsiode on long-term renal allograft survival (tl/2)
124. Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by VLA-5 fibronectin receptor complex
125. Leucocyte rolling and extravasation are severely compromised in P-selectin-deficient mice
126. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection
127. Cardiac transplant coronary artery disease. A multivariable analysis of pretransplantation risk factors for disease development and morbid events
128. Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK506 in a rat heart allograft model
129. Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM 23014C) effect on the generation of allograft arteriosclerosis
130. Reversibility of allograft arteriosclerosis after retransplantation to donor strain
131. Chronic rejection in rat allografts. IV. Effect of hypercholesterolemia in allograft arteriosclerosis
132. Effect of perindopril on the immune arterial wall remodeling in the rat model of arterial graft rejection
133. The effect of kidney size on cadaveric renal allograft outcome
134. Intertubular capillary changes in kidney allografts: An ultra-structural study in patients with transplant glomerulopathy
135. Sequential cytokine dynamics in chronic rejection of rat renal allografts: Roles for cytokines RANTES and MCP-1
136. Coronary arteriosclerosis after T-cell mediated injury in transplanted mouse hearts: Role of interferon-γ
137. Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts
138. Deficiencies of IL-4 or TNF-α R1 do not diminish graft arteriosclerosis in cardiac allografts
139. Acute rejection accelerates graft coronary disease in transplanted rabbit hearts
140. Long-term follow-up after partial removal of a solitary kidney
141. Cytomegalovirus infection and donor/recipient HLA antigens: Inter-dependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation
142. HLA-antibody production correlates strongly with chronic renal allograft rejection
143. Delayed graft function: Risk factors and implications for renal allograft survival
144. Chronic graft loss in kidney and heart transplant recipients
145. Critical evaluation of the association between acute and chronic graft rejection in kidney and heart transplant recipients
146. Association of chronic kidney graft failure with recipient blood pressure
147. Vascular endothelial alloantigens in renal transplantaton
148. Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: Proposal from the Fourth Alexis Carrel Conference on Chronic rejection and accelerated arteriosclerosis in transplanted organs
149. Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat
150. Growth factor transcripts in rat renal transplants
151. Cold ischemia and outcome in 17937 cadaveric kidney transplants
152. Relation between survival and development of coronary disease and anti-HLA antibodies after cardiac transplantation
153. Determinants of graft survival after renal transplantation
154. Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor, and immune interferon
155. Hypertension after renal transplantation
156. Obliterative vascular changes in four human kidney homotransplants
157. Effects of increased ICAM-1 on reperfusion injury and chronic graft vascular disease
158. Acute rejection of rat renal allografts is accelerated by donor brain death
159. Activation of proinflammatory genes in somatic organs as a consequence of brain death
160. Risk factors for the development of accelerated coronary artery disease in cardiac transplant recipients
161. Does antihypertenisve therapy modify chronic allograft failure?
162. Transplantation of single and paired pediatric kidneys into adult recipients
163. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary disease
164. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation
165. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion
166. Relation of HLA antibodies and graft atherosclerosis in human cardiac transplant recipients
167. The pathogenesis of atherosclerosis: A perspective for 1990 s
168. Immunofluorescent localization of human immunoglobulin in tissues from cardiac allograft recipients
169. Chronic cardiac rejection in the Lew to F344 rat model. Blockade of CD28-DB7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis
170. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection
171. Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: Lack of progression to sclerotic lesions in B cell-deficient mice
172. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity
173. Specific effects of oestrogen on growth factors and MHC class II expression in rat aorta allograft
174. Human coronary transplantation-associated arteriosclerosis: Evidence for a chronic immune reaction to activated graft endothelial cells
175. An alternative view minimizing the Significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidey transplant recipients
176. Factors contributing to the developement of chronic rejection in heterotopic rat heart transplantation
177. Causes of renal allograft loss: Progress in the 80 s, challenges for the 90 s
178. Determinants of graft arteriosclerosis after heart transplantation
179. Cytokine IL-2, TNFα and IFNγ release after ischemia reperfusion injury in a novel lung autograft animal model
180. Analysis of the T cell repertoire in man
181. Donor MHC and adhesion molecules in transplant arteriosclerosis
182. Immunologic basis of transplant-associated arteriosclerosis
183. Transforming growth factor-β and matrix protein expression in acute and chronic rejection of human renal allografts
184. A progressive glomerulosclerosis occurring in partial five-sixth nephrectomized rats
185. Intrathymic injection of donor splenocytes plus systemic antilymphocyte serum or antilymphocyte serum alone prolongs cardiac allograft survival and inhibits graft arteriosclerosis in the Lewis-to-F344 chronic rejection model
186. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection
187. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse
188. Indirect presentation of MHC antigens in transplantation
189. Histopathology of chronic rejection
190. Specificity of lymphocytotoxic antibodies formed after cardiac transplantation and correlation with rejection episodes
191. Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching
192. CsA levels in the early posttransplant period-predictive of chronic rejection in liver transplantation?
193. International standardization of nomenclature and criteria for the histologic diagnosis of renal allograft rejection: The BANFF working classification of kidney transplant patology
194. International standardization of criteria for histologic diagnosis of chronic rejection in renal allografts
195. Traffic signals on endothelium for lymphocyte recirculation and leucocyte emigration
196. Development of chronic injury and nature of interstial infiltrate in a model of chronic renal allograft rejection
197. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporin
198. The Th1/Th2 paradigm and the allograft response
199. Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients
200. The role of anti-HLA antibodies in heart transplantation
201. HLA-identical renal transplants: Impact of cyclosporine on intermediate-term survival survival and renal function
202. Pottransplant serum creatinine under the curve predicts renal allograft outcome
203. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody
204. Molecular analyses of human renal allografts: Differential intragraft gene expression during rejection
205. The role of the B7 costimulatory pathway in experimental ischemia/reperfusion injury
206. Effects of explosive brain death on cytokine activation of peripheral organs in the rat
207. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand
208. Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding
209. Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts
210. High survival rates of kidney transplants from spousal and living unrelated donors
211. Thirty-year trends in clinical kidney transplantation
212. Long-term results of kidney transplantation in Eurotransplant
213. Phenotype modulation in primary cultures of arterial smooth muscle cells
214. Rejected human renal allografts: Recovery and characteristics of infiltrating cells and antibody
215. Retransplantation after renal allograft loss due to noncompliance
216. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation
217. Reversibility of chronic renal allograft rejection. Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury
218. Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection
219. Early ischemic injury leads to long-term functional and morphologic deterioration of naive rat kidneys and may contribute to changes of chronic allograft rejection
220. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection
221. The impact of acute rejection on the long-term incidence after renal transplantation
222. Absence of deleterious effect on long-term kidney graft survival of rejection episodes with complete functional recovery
223. Ischemia-induced transplant arteriosclerosis in the rat
224. Cytokine and alloantibody networks in long-term cardiac allografts in rat recipients treated with rapamycin
225. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement
226. Cloning of the mouse endothelial selectins: Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha
227. Donor brain death affects tempo and intensity of acute rejection of rat cardiac allografts
228. Pharmacologically induced regression of chronic transplant rejection
229. Incidence and progression of transplant coronary artery disease over 1 year: Results of a multicenter trial with use of intravascular ultrasound
230. The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts
231. Chronic renal allograft rejection can be predicted by the surface area under the serum creatinine versus time curve
232. Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression
233. Chronic rejection of rat renal allografts II. The impact of prolonged ischemia time on transplant histology
234. CD4 + T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver